Mohammad Saleh

Mohammad is a PhD student in Biomedical Engineering at the University of Toronto. He completed a Masters in Immunology and a Bachelors degree in Engineering Science from UToronto (major in Biomedical Systems Engineering). He is working on developing synthetic receptors, cell-based vaccines, and on immuno-cloaking to enable the use of synthetic biology in cell therapies. His interests and previous work at UToronto and Harvard Medical School encompassed immunoengineering, tumor immunology, and regenerative medicine.

Author's Posts

Cardiology

February 21st, 2020 In a world where cardiovascular diseases are the leading cause of death (with an estimated 17.9 million annual deaths globally, according to the WHO), the need to accurately and reliably monitor patients following cardiac procedures is ever-growing. This need is highlighted by the frequency of complications that occur following such...
Exclusive

January 3rd, 2019 If you follow the recent advances in medical technology and artificial intelligence, you may have heard people make bold claims that AI will replace tomorrow’s doctors. While there are still ways to go for technology to reach these sci-fi levels, many companies are actively designing AI systems that will accompany doctors or assist...
Cardiology

December 17th, 2018 In the summer of 2018, VitalConnect launched the VistaTablet as an extension to their FDA-approved biosensor, the VitalPatch, which measures eight vital parameters. We have previously covered the VitalPatch and the launch of the VistaTablet, but we recently had the chance to check them out first-hand. The following is a review of...
Next page
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.